Key takeaways:
Vtama (tapinarof) is a topical medication used to treat plaque psoriasis in adults. It’s applied to affected areas of your skin once daily.
Unlike many other plaque psoriasis medications, Vtama isn’t a steroid or a biologic, but it appears to slow the rapid buildup of skin cells and relieve inflammation. Vtama can start working right after you apply it, but it may take several weeks to see a difference. Some people might notice improvement in symptoms within a week of starting.
How long you apply Vtama may depend on how you respond to treatment. If you achieve clear skin after 12 weeks, you may be told to stop Vtama. And if your psoriasis symptoms return, you may be told to restart Vtama. Some people may need to apply Vtama continually, while others might achieve clear skin without needing retreatment.
Before the FDA approved Vtama (tapinarof) in 2022, there hadn’t been a new topical treatment with a unique chemical structure for plaque psoriasis in 25 years. Here, we will look at how Vtama works and compares with other options.
A common question is how long it takes Vtama to work. And you may want to know how long you’ll need to apply Vtama, since many topical treatments have a limited duration of use because of side effects. We answer these questions and more below.
Vtama is a topical treatment for plaque psoriasis in adults. It is one of the newest plaque psoriasis medications, and it can be used for mild, moderate, or severe cases. Vtama comes as a topical cream that’s applied to affected areas of skin once daily.
In addition to plaque psoriasis, Vtama is being studied to treat atopic dermatitis (eczema) in adults and children ages 2 and older.
Skin deep: There are many creams, ointments, and lotions available for psoriasis, including prescription and over-the-counter options. Experts review topical psoriasis treatments to help you decide which is best for you.
Options available: Your psoriasis treatment plan may involve topical medications, pills, injections, and even light therapy. Learn more about how psoriasis treatment options compare.
Real stories: Psoriasis can affect everyone differently. And it can be unpredictable and change over time. Three people living with psoriasis share what has worked — and hasn’t worked — to help them find relief.
No. Unlike many other topical plaque psoriasis treatments, Vtama is not a steroid.
Instead, Vtama is considered an aryl hydrocarbon receptor agonist. Researchers don’t fully understand how it works for plaque psoriasis. But Vtama appears to help lessen skin inflammation and slow the rapid buildup of skin cells.
Why is having steroid-free options important? Topical steroids can cause skin thinning and other rare but serious effects, especially with long-term use or when they’re applied to large areas of thin skin. Topical steroids can also cause topical steroid withdrawal after you stop using them. This can cause symptoms such as skin inflammation, itching, and flaking.
Vtama starts working after you apply it, but you may not notice a difference in your skin right away. Some people report reduced itching within the first week. And you may start to see improvements in your psoriasis within several weeks of treatment.
Vtama doesn’t work for everyone, and people can respond differently to treatment. About 40% of people during initial clinical trials reported clear or almost-clear skin after 12 weeks of applying Vtama. And during a 1-year safety and efficacy trial, almost 60% of people starting with mild to severe plaque psoriasis achieved clear or almost-clear skin.
How long you’ll use Vtama depends on how you respond to treatment. If your skin is clear after 12 weeks of use, you may be told to stop Vtama. And if your psoriasis symptoms come back, you may be instructed to apply Vtama until your skin clears up again.
During clinical trials, people who achieved clear skin with Vtama were able to maintain this result for an average of 4 months after stopping the medication. Some people whose skin cleared up didn’t need to restart Vtama during the study period, while others required intermittent (occasional) or continual treatment.
Your prescriber will determine how long you should take Vtama. They can tailor your treatment based on your individual response and needs.
It depends. Vtama is available as a 60 gram tube. How long your Vtama tube lasts will depend on what areas of skin you need to apply it to. Vtama should be applied externally only to psoriasis skin lesions, not unaffected skin.
Remember to protect your Vtama tube from temperature extremes. It should be stored at room temperature, which is 68°F to 77°F.
No. Vtama is not one of the biologic medications used for psoriasis.
Biologics are medications that come from living sources. They’re usually given as injections, either subcutaneous (under the skin) or intravenous (into the vein). Vtama is a chemical-based medication that’s made by mixing powders and liquids into a base to create a cream.
Vtama (tapinarof) is a topical prescription medication used to treat plaque psoriasis in adults. It’s applied to psoriasis skin lesions once daily.
Many people report clearer skin within 12 weeks of starting Vtama. Some people may be able to stop Vtama and not require retreatment after achieving clear skin. But others may need to use it intermittently (occasionally) or continually. This can depend on how you respond to treatment.
Vtama isn’t a steroid. And it isn’t a biologic. If you have additional questions about Vtama, talk to your prescriber or pharmacist.
Dermavant Sciences. (2022). FDA approves Dermavant’s VTAMA (tapinarof) cream, 1% for the treatment of plaque psoriasis in adults: First topical novel chemical entity launched for psoriasis in the U.S. in 25 years.
Dermavant Sciences. (2023). Dermavant presents positive results from phase 4 open-label trial of Vtama (tapinarof) cream, 1% for the treatment of intertriginous plaque psoriasis in adults at 43rd Annual Fall Clinical Dermatology Conference.
Dermavant Sciences. (2023). Dermavant reports positive topline results from ADORING 1, the second atopic dermatitis phase 3 trial of Vtama (tapinarof) cream, 1% in adults and children as young as 2 years old.
Dermavant Sciences. (2023). Vtama- tapinarof cream [package insert].
Lebwohl, M. G., et al. (2021). Phase 3 trials of tapinarof cream for plaque psoriasis. New England Journal of Medicine.
Strober, B., et al. (2022). One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial. Journal of the American Academy of Dermatology.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.